Searched for
INDEPENDENT PHARMA REGULATOR
Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
Chinese business hired lobbying firm with ties to Donald Trump Jr, then scored a win in WashingtonA U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...
Regulating pharma, beyond manufacturing qualityIn a significant leap forward, India's drug authority, CDSCO, is poised for a transformative upgrade. The government is embarking on an ini...
Be horrified, we can't let our children dieA tragic repeat of the 1937 Elixir Sulfanilamide disaster, where diethylene glycol (DEG) killed 107 people, has occurred in India. In Augus...
'WHO has lost its independence, Indian govt should exit global health body'Almost always and without an exception, the results of clinical trials of drugs are published in the most prestigious medical journals, whi...
Good Med abroad is good Med for homeThe Directorate General of Foreign Trade (DGFT) has made it mandatory for all cough syrup exporters to have their product tested and certif...
Quality of pharma must not be strainedNews that 48 common drugs manufactured in India failed to meet quality standards comes as little surprise. The absence of a robust drug reg...
Indian pharma to step up quality standard to meet global generic demandIn 2019, Indian pharma companies received 19 warning letters. Nearly half were from the Office of Manufacturing Quality, US Food and Drug A...
Trend of tighter corporate governance expected to continue into the New YearShareholder activism, new regulations, whistleblowers and social media have ensured that companies improve governance
Govt to amend norms to empower NPPA to fix prices of 350 drugsThe price regulator will ensure that all medicines are regulated and are available at affordable rates to the public.
Pharma stocks trade at 'stratospheric' valuations; upside limited: Anand TandonMost of the pharma stocks barring a few, are probably at a range where there is not that much left on the table, says Tandon.
Sun Pharma's open offer 'fair', says Zenotech panelZenotech Laboratories has termed Sun Pharma's open offer worth Rs 20.23 crore to acquire a little over 28 per cent stake in the company as ...
Andhra HC vacates status quo order on Sun Pharma-Ranbaxy mergerThe Andhra Pradesh high court on Saturday vacated stay orders it issued last month on the merger of two firms that would create world’s fou...
GuruFcure in row for fabricating data while seeking nod for making seven combination drugsPuducherry-based drugmaker GuruFcure has come under the scanner for allegedly submitting fabricated data.
Pharma companies to compensate for clinical trial death, injuryThe decision to make compensation mandatory in such cases comes four weeks after the Supreme Court chided the government for its sloppy reg...
- Sun Pharma plans to delist Caraco, offers share buyback
Sun Pharma said it plans to delist its Detroit-based subsidiary Caraco Pharma from the US bourses by acquiring all the shares of it.
- Drug recall to have minimal impact on Sun
India’s largest drugmaker by market capitalisation Sun Pharma whose US arm recalled one of the products sold in the world’s largest drug ma...